Articles By Jack Cush, MD
RheumNow Podcast – Delays in Diagnosis (3.8.19)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com
Read Article
Multiple Delays in Referral of New RA Patients
A UK study of early onset arthritis or new rheumatoid arthritis patients shows multiple sources of delayed referral to the first rheumatology consultation.
Read Article
Biologic Agents have Equal Efficacy in Enthesitis and Dactylitis
A systematic review has shown that TNF inhibitors (TNFi) are equaled in efficacy by other biologic agents (ustekinumab, secukinumab, and ixekizumab) in psoriatic arthritis (PsA) patients with in dactylitis and enthesitis.
Read Article
Lower Mortality Results from Lower Activity in Lupus
Data from the longitudinal Tromsø Lupus Cohort study has shown that lupus patients who achieve a Lupus Low Disease Activity State (LLDAS‐50) were shown to have significantly less severe damage, and a reduction in mortality. This was a population‐based study of SLE patients in the northern‐most counties of Norway.
Read Article
AAD/NPF Guidelines on Biologic Use in Psoriasis
Menter and colleagues from the American Academy of Dermatology (AAD) and National Psoriasis Foundation (NPF) have published their expert consensus guidelines for the use of biologics in psoriasis.
Read Article
Dermatology Guidelines for Psoriatic Comorbidities
The JAAD has published joint guidelines from the American Academy of Dermatology (AAD) and National Psoriasis Foundation (NPF) on the approach, management and dermatolgist roles for select comorbid conditions.
Read Article
RheumNow Podcast – Scleroderma and the Lung (3.1.19)
Dr. Jack Cush Reviews the news and journal articles from the past week on RheumNow.com
Read Article
Early TNF inhibition in Early Psoriatic Arthritis
A small, double-blind, randomised, placebo-controlled trial in early psoriatic arthritis (PsA) has shown that first-line use of golimumab and methotrexate (MTX) is superior to MTX alone in inducing remission in PsA.
Read Article
Allopurinol Reduces Cardiovascular Outcomes in Diabetes
A Canadian study has shown that elderly diabetics who take allopurinol have a significant reduction in cardiovascular outcomes.
Read Article
Senate Drills Drug Makers Over Price
Reuters reported that today, the US Senate Finance Committee met to question the executives from seven US pharmaceutical companies on the rising price drugs in America.
Read Article
